Membrane proteins, PTMs, idiotypes, or haptens giving you a hard time? We specialize in turning complex targets into concrete results.
Request a Quote
We go beyond the target—to deliver precision, creativity, and results.
From complex membrane proteins to invisible haptens—we’ve tackled it all.
Specialized solutions for post-translational modifications and idiotype recognition.
Phage, yeast, and mammalian display systems to suit the nature of your target.
From antigen design to validated binders—we’re your one-stop antibody shop.
A comprehensive workflow from target evaluation to validated deliverables
We discuss your specific target, challenges, and project goals, then propose a custom approach tailored to your target's unique properties.
Depending on your target, we prepare full-length proteins, PTM-modified peptides, hapten conjugates, or idiotype-mimics, and tailor the right screening libraries.
High-throughput screening using phage/yeast display or hybridoma technologies, followed by affinity optimization and isotype selection to enhance target specificity.
Functional validation and delivery of purified antibody clones, sequences, and full characterization data to support your research goals.
Discover the difference our specialized platforms can make for your target type
Membrane proteins are notoriously difficult to express, purify, and use as immunogens—but they are also among the most critical drug targets. At Creative Biolabs, we leverage a combination of liposome reconstitution, nanodisc technology, and cell-based antigen presentation to preserve native conformation. Our antibody discovery platforms are customized to address the hydrophobicity and low immunogenicity of membrane proteins.
PTMs like phosphorylation, methylation, ubiquitination, and glycosylation regulate protein function with surgical precision—and so should your antibodies. We design immunogens with exquisite selectivity and offer discovery platforms that distinguish modified from unmodified sequences.
Anti-idiotype antibodies are indispensable tools for therapeutic antibody quantification, biosimilar development, vaccine research, and immune regulation. At Creative Biolabs, we specialize in generating high-affinity anti-ID antibodies, including three distinct types: antigen blocking type (inhibitory), antigen non-blocking type (non-inhibitory), drug-target complex specific type.
Small molecules like toxins, pesticides, and drugs are too small to elicit immune responses—unless conjugated correctly. We specialize in hapten-carrier conjugation and screening methods that produce high-affinity, highly specific antibodies suitable for research.
Creative Biolabs has built a diverse and flexible platform portfolio tailored to tackle membrane proteins, PTMs, idiotypes, and haptens
Rapid screening of conformation-sensitive antibodies using nanodisc or cell-based display systems for complex membrane targets.
Explore Phage Display →
Traditional monoclonal antibody production enhanced with liposome-presented antigens for native structure recognition.
Explore Hybridoma Discovery →
Live-cell based antigen presentation preserves native topology for high-specificity membrane protein antibody discovery.
Explore B Cell Sorting →
Accelerated screening using ready-to-go human, mouse, and camelid libraries against membrane proteins, PTMs, and other challenging targets.
Explore Premade Libraries →
Explore our proven strategies for tackling tough targets—Native™ platform, phage display, hybridoma, and more—in one easy-to-digest infographic.
Download NowYes—and we take it seriously. Our PTM workflows include strict counter-screening against unmodified peptides and competitors, so we don’t just find binders—we find specific ones.
Absolutely. We’ll start by reviewing your application (PK tracking, vaccine, etc.) and recommend Ab2α, Ab2β, or Ab2γ types. You're never alone in choosing the right idiotype strategy.
Not at all! Just send us the structure. Our chemists will design the optimal linker and carrier conjugation, synthesize the immunogen, and handle the rest—we’ve done this for years.
You’ll get purified antibodies (or clones), sequence info (if applicable), binding affinity data, ELISA/Western results, and a detailed report—everything ready for publication or validation.
Yes. For recombinant workflows, we deliver full-length sequences (VH/VL or scFv), and for hybridomas, we offer sequencing and subcloning upon request. This ensures long-term reproducibility and future recombinant manufacturing without loss of function.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.